OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	168.87B +4.0%
Revenue (ttm)	14.19B +30.0%
Net Income	201.02M
EPS	1.75
Shares Out	114.62M
PE Ratio	840.07
Forward PE	52.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	508,724
Average Volume	413,523
Open	1,403.00
Previous Close	1,447.10
Day's Range	1,384.10 - 1,487.90
52-Week Range	1,057.00 - 2,248.00
Beta	n/a
RSI	56.92
Earnings Date	May 7, 2026

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,412
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In fiscal year 2025, NSE:ONESOURCE's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2024.